Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
JAMA. 2020 Mar 24;323(12):1151-1160. doi: 10.1001/jama.2020.1382.
It is unclear whether the number of steps per day and the intensity of stepping are associated with lower mortality.
Describe the dose-response relationship between step count and intensity and mortality.
DESIGN, SETTING, AND PARTICIPANTS: Representative sample of US adults aged at least 40 years in the National Health and Nutrition Examination Survey who wore an accelerometer for up to 7 days ( from 2003-2006). Mortality was ascertained through December 2015.
Accelerometer-measured number of steps per day and 3 step intensity measures (extended bout cadence, peak 30-minute cadence, and peak 1-minute cadence [steps/min]). Accelerometer data were based on measurements obtained during a 7-day period at baseline.
The primary outcome was all-cause mortality. Secondary outcomes were cardiovascular disease (CVD) and cancer mortality. Hazard ratios (HRs), mortality rates, and 95% CIs were estimated using cubic splines and quartile classifications adjusting for age; sex; race/ethnicity; education; diet; smoking status; body mass index; self-reported health; mobility limitations; and diagnoses of diabetes, stroke, heart disease, heart failure, cancer, chronic bronchitis, and emphysema.
A total of 4840 participants (mean age, 56.8 years; 2435 [54%] women; 1732 [36%] individuals with obesity) wore accelerometers for a mean of 5.7 days for a mean of 14.4 hours per day. The mean number of steps per day was 9124. There were 1165 deaths over a mean 10.1 years of follow-up, including 406 CVD and 283 cancer deaths. The unadjusted incidence density for all-cause mortality was 76.7 per 1000 person-years (419 deaths) for the 655 individuals who took less than 4000 steps per day; 21.4 per 1000 person-years (488 deaths) for the 1727 individuals who took 4000 to 7999 steps per day; 6.9 per 1000 person-years (176 deaths) for the 1539 individuals who took 8000 to 11 999 steps per day; and 4.8 per 1000 person-years (82 deaths) for the 919 individuals who took at least 12 000 steps per day. Compared with taking 4000 steps per day, taking 8000 steps per day was associated with significantly lower all-cause mortality (HR, 0.49 [95% CI, 0.44-0.55]), as was taking 12 000 steps per day (HR, 0.35 [95% CI, 0.28-0.45]). Unadjusted incidence density for all-cause mortality by peak 30 cadence was 32.9 per 1000 person-years (406 deaths) for the 1080 individuals who took 18.5 to 56.0 steps per minute; 12.6 per 1000 person-years (207 deaths) for the 1153 individuals who took 56.1 to 69.2 steps per minute; 6.8 per 1000 person-years (124 deaths) for the 1074 individuals who took 69.3 to 82.8 steps per minute; and 5.3 per 1000 person-years (108 deaths) for the 1037 individuals who took 82.9 to 149.5 steps per minute. Greater step intensity was not significantly associated with lower mortality after adjustment for total steps per day (eg, highest vs lowest quartile of peak 30 cadence: HR, 0.90 [95% CI, 0.65-1.27]; P value for trend = .34).
Based on a representative sample of US adults, a greater number of daily steps was significantly associated with lower all-cause mortality. There was no significant association between step intensity and mortality after adjusting for total steps per day.
重要性:每天的步数和步频与死亡率的关系尚不清楚。
目的:描述步数和步频与死亡率之间的剂量-反应关系。
设计、地点和参与者:这项研究的参与者为美国至少 40 岁的代表性成年人,他们在国家健康和营养调查中佩戴了加速度计,最长佩戴 7 天(2003-2006 年)。通过 2015 年 12 月确定死亡率。
暴露情况:通过加速度计测量的每天的步数和 3 个步频指标(延长节拍速率、30 分钟峰值节拍速率和 1 分钟峰值节拍速率[步/分钟])。加速度计数据基于基线 7 天期间的测量结果。
主要结果和措施:主要结局是全因死亡率。次要结局是心血管疾病(CVD)和癌症死亡率。使用三次样条和四分位分类法估计危险比(HR)、死亡率和 95%置信区间,同时调整年龄、性别、种族/民族、教育、饮食、吸烟状况、体重指数、自我报告的健康状况、活动能力受限以及糖尿病、中风、心脏病、心力衰竭、癌症、慢性支气管炎和肺气肿的诊断情况。
结果:共有 4840 名参与者(平均年龄 56.8 岁;2435 名[54%]女性;1732 名[36%]肥胖者)佩戴加速度计的平均时间为 5.7 天,每天平均佩戴 14.4 小时。平均每天的步数为 9124 步。在平均 10.1 年的随访中,共有 1165 人死亡,包括 406 例 CVD 死亡和 283 例癌症死亡。在未经调整的情况下,每天步数少于 4000 步的 655 人中,全因死亡率的发生率密度为 76.7/1000 人年(419 例死亡);每天步数为 4000 至 7999 步的 1727 人中,全因死亡率的发生率密度为 21.4/1000 人年(488 例死亡);每天步数为 8000 至 11999 步的 1539 人中,全因死亡率的发生率密度为 6.9/1000 人年(176 例死亡);每天步数至少 12000 步的 919 人中,全因死亡率的发生率密度为 4.8/1000 人年(82 例死亡)。与每天步数 4000 步相比,每天 8000 步与全因死亡率显著降低相关(HR,0.49[95%CI,0.44-0.55]),每天 12000 步也是如此(HR,0.35[95%CI,0.28-0.45])。未经调整的全因死亡率发生率密度,按 30 分钟峰值步频计算,每分钟 18.5 至 56.0 步的 1080 人中为 32.9/1000 人年(406 例死亡);每分钟 56.1 至 69.2 步的 1153 人中为 12.6/1000 人年(207 例死亡);每分钟 69.3 至 82.8 步的 1074 人中为 6.8/1000 人年(124 例死亡);每分钟 82.9 至 149.5 步的 1037 人中为 5.3/1000 人年(108 例死亡)。调整每天总步数后,较高的步频强度与死亡率降低之间没有显著关联(例如,最高与最低四分位的 30 分钟峰值步频:HR,0.90[95%CI,0.65-1.27];趋势检验 P 值=0.34)。
结论和相关性:基于美国成年人的代表性样本,每天的步数越多与全因死亡率降低显著相关。在调整每天总步数后,步频强度与死亡率之间没有显著关联。